CELEK PHARMACEUTICALS, LLC

Basic Information

119 UPSHIRE CIR
GAITHERSBURG, MD, 20878-5215

Company Profile

n/a

Additional Details

Field Value
DUNS: 831413419
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. TAS::75 0849::TAS TOPIC 255: A TARGETED DRUG FOR NON-MUSCLE INVASIVE BLADDER CANCER

    Amount: $176,266.00

    CEL-031 is being developed as a novel, targeted tre8tment for non-mLiscle invasive bladder cancer (NMIBC). Bladder cancer is the 5th most common cancer in the US, with most cases diagnosed 8t the non ...

    SBIR Phase I 2011 Department of Health and Human Services
  2. Developing a Novel Peptide Therapeutic for Interstitial Cystitis/Painful Bladder

    Amount: $180,571.00

    DESCRIPTION (provided by applicant): The overall goals of the proposed phase 1 SBIR project are to investigate the in vivo efficacy and mechanism of action of a novel, first-in-class drug candidate fo ...

    SBIR Phase I 2010 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government